{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T15:50:10Z","timestamp":1765295410334,"version":"3.37.3"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T00:00:00Z","timestamp":1691107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T00:00:00Z","timestamp":1691107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009275","name":"DeGregorio Family Foundation","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100009275","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s10689-023-00346-z","type":"journal-article","created":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T09:01:35Z","timestamp":1691139695000},"page":"521-526","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Combining clinical and molecular characterization of CDH1: a multidisciplinary approach to reclassification of a splicing variant"],"prefix":"10.1007","volume":"22","author":[{"given":"Corrine","family":"Fillman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arravinth","family":"Anantharajah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Briana","family":"Marmelstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Dillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn","family":"Horton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Candace","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rashmi","family":"Tondon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terra","family":"Brannan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryson W","family":"Katona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,4]]},"reference":[{"key":"346_CR1","doi-asserted-by":"publisher","first-page":"e386","DOI":"10.1016\/S1470-2045(20)30219-9","volume":"21","author":"VR Blair","year":"2020","unstructured":"Blair VR, McLeod M, Carneiro F et al (2020) Hereditary diffuse gastric cancer: updated clinical practice guidelines. Lancet Oncol 21:e386\u2013e397. https:\/\/doi.org\/10.1016\/S1470-2045(20)30219-9","journal-title":"Lancet Oncol"},{"key":"346_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1001\/jamaoncol.2014.168","volume":"1","author":"S Hansford","year":"2015","unstructured":"Hansford S, Kaurah P, Li-Chang H et al (2015) Hereditary diffuse gastric Cancer syndrome: CDH1 mutations and Beyond. JAMA Oncol 1:23\u201332. https:\/\/doi.org\/10.1001\/jamaoncol.2014.168","journal-title":"JAMA Oncol"},{"key":"346_CR3","doi-asserted-by":"publisher","first-page":"104316","DOI":"10.1016\/j.ejmg.2021.104316","volume":"64","author":"S Lobo","year":"2021","unstructured":"Lobo S, Benusiglio PR, Coulet F et al (2021) Cancer predisposition and germline CTNNA1 variants. Eur J Med Genet 64:104316. https:\/\/doi.org\/10.1016\/j.ejmg.2021.104316","journal-title":"Eur J Med Genet"},{"key":"346_CR4","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/s41436-020-0753-1","volume":"22","author":"DF Clark","year":"2020","unstructured":"Clark DF, Michalski ST, Tondon R et al (2020) Loss-of-function variants in CTNNA1 detected on multigene panel testing in individuals with gastric or breast cancer. Genet Med 22:840\u2013846. https:\/\/doi.org\/10.1038\/s41436-020-0753-1","journal-title":"Genet Med"},{"key":"346_CR5","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1053\/gast.2001.29611","volume":"121","author":"PD Pharoah","year":"2001","unstructured":"Pharoah PD, Guilford P, Caldas C, International Gastric Cancer Linkage Consortium (2001) Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology 121:1348\u20131353. https:\/\/doi.org\/10.1053\/gast.2001.29611","journal-title":"Gastroenterology"},{"key":"346_CR6","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1136\/jmedgenet-2019-105991","volume":"56","author":"RM Xicola","year":"2019","unstructured":"Xicola RM, Li S, Rodriguez N et al (2019) Clinical features and cancer risk in families with pathogenic CDH1 variants irrespective of clinical criteria. J Med Genet 56:838\u2013843. https:\/\/doi.org\/10.1136\/jmedgenet-2019-105991","journal-title":"J Med Genet"},{"key":"346_CR7","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1001\/jamaoncol.2019.1208","volume":"5","author":"ME Roberts","year":"2019","unstructured":"Roberts ME, Ranola JMO, Marshall ML et al (2019) Comparison of CDH1 Penetrance estimates in clinically ascertained families vs families ascertained for multiple gastric cancers. JAMA Oncol 5:1325\u20131331. https:\/\/doi.org\/10.1001\/jamaoncol.2019.1208","journal-title":"JAMA Oncol"},{"key":"346_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/PO.16.00021","volume":"1","author":"K Lowstuter","year":"2017","unstructured":"Lowstuter K, Espenschied CR, Sturgeon D et al (2017) Unexpected CDH1 mutations identified on Multigene Panels Pose Clinical Management Challenges. JCO Precis Oncol 1:1\u201312. https:\/\/doi.org\/10.1200\/PO.16.00021","journal-title":"JCO Precis Oncol"},{"key":"346_CR9","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1093\/jnci\/djz229","volume":"112","author":"BW Katona","year":"2020","unstructured":"Katona BW, Clark DF, Domchek SM (2020) CDH1 on Multigene Panel Testing: look before you Leap. J Natl Cancer Inst 112:330\u2013334. https:\/\/doi.org\/10.1093\/jnci\/djz229","journal-title":"J Natl Cancer Inst"},{"key":"346_CR10","unstructured":"Daly MB et al (2023) PTAZ. National Comprehensive Cancer Network. Genetic\/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic."},{"key":"346_CR11","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1245\/s10434-019-07549-8","volume":"26","author":"ER Manahan","year":"2019","unstructured":"Manahan ER, Kuerer HM, Sebastian M, Hughes KS, Boughey JC, Euhus DM, Boolbol SK, Taylor WA (2019) Consensus Guidelines on Genetic` testing for Hereditary breast Cancer from the american society of breast surgeons. Ann Surg Oncol 26:3025\u20133031. https:\/\/doi.org\/10.1245\/s10434-019-07549-8","journal-title":"Ann Surg Oncol"},{"key":"346_CR12","doi-asserted-by":"publisher","unstructured":"Federici G, Soddu S (2020) Variants of uncertain significance in the era of high-throughput genome sequencing: a lesson from breast and ovary cancers. J Experimental Clin Cancer Res 39:46.  https:\/\/doi.org\/10.1186\/s13046-020-01554-6","DOI":"10.1186\/s13046-020-01554-6"},{"key":"346_CR13","doi-asserted-by":"publisher","unstructured":"Idos GE, Kurian AW, Ricker C et al (2019) Multicenter prospective cohort study of the Diagnostic yield and patient experience of Multiplex Gene Panel Testing for Hereditary Cancer Risk. https:\/\/doi.org\/10.1200\/po.18.00217. JCO Precis Oncol","DOI":"10.1200\/po.18.00217"},{"key":"346_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41436-020-00957-2","volume":"23","author":"C Mighton","year":"2021","unstructured":"Mighton C, Shickh S, Uleryk E et al (2021) Clinical and psychological outcomes of receiving a variant of uncertain significance from multigene panel testing or genomic sequencing: a systematic review and meta-analysis. Genet Sci 23:22\u201333. https:\/\/doi.org\/10.1038\/s41436-020-00957-2","journal-title":"Genet Sci"},{"key":"346_CR15","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1136\/jmedgenet-2021-108169","volume":"60","author":"BA Lerner","year":"2023","unstructured":"Lerner BA, Xicola RM, Rodriguez NJ, Karam R, Llor X (2023) Simplified and more sensitive criteria for identifying individuals with pathogenic CDH1 variants. J Med Genet 60:36\u201340. https:\/\/doi.org\/10.1136\/jmedgenet-2021-108169","journal-title":"J Med Genet"},{"key":"346_CR16","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/j.jmoldx.2020.09.007","volume":"22","author":"P Rofes","year":"2020","unstructured":"Rofes P, Men\u00e9ndez M, Gonz\u00e1lez S et al (2020) Improving genetic testing in Hereditary Cancer by RNA analysis: tools to prioritize Splicing Studies and Challenges in applying American College of Medical Genetics and Genomics Guidelines. J Mol Diagn 22:1453\u20131468. https:\/\/doi.org\/10.1016\/j.jmoldx.2020.09.007","journal-title":"J Mol Diagn"},{"key":"346_CR17","doi-asserted-by":"publisher","first-page":"e1913900","DOI":"10.1001\/jamanetworkopen.2019.13900","volume":"2","author":"R Karam","year":"2019","unstructured":"Karam R, Conner B, LaDuca H et al (2019) Assessment of Diagnostic Outcomes of RNA genetic testing for Hereditary Cancer. JAMA Netw Open 2:e1913900. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.13900","journal-title":"JAMA Netw Open"},{"key":"346_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nrg.2015.3","volume":"17","author":"MM Scotti","year":"2016","unstructured":"Scotti MM, Swanson MS (2016) RNA mis-splicing in disease. Nat Rev Genet 17:19\u201332. https:\/\/doi.org\/10.1038\/nrg.2015.3","journal-title":"Nat Rev Genet"},{"key":"346_CR19","doi-asserted-by":"publisher","first-page":"e1007231","DOI":"10.1371\/journal.pgen.1007231","volume":"14","author":"CL Rhine","year":"2018","unstructured":"Rhine CL, Cygan KJ, Soemedi R et al (2018) Hereditary cancer genes are highly susceptible to splicing mutations. PLoS Genet 14:e1007231. https:\/\/doi.org\/10.1371\/journal.pgen.1007231","journal-title":"PLoS Genet"},{"key":"346_CR20","doi-asserted-by":"publisher","first-page":"4464","DOI":"10.3390\/cancers13174464","volume":"13","author":"R Barbosa-Matos","year":"2021","unstructured":"Barbosa-Matos R, Silva L, Garrido R, L. et al (2021) The CDH1 c.1901\u00a0C > T variant: a founder variant in the Portuguese Population with severe impact in mRNA splicing. Cancers 13:4464. https:\/\/doi.org\/10.3390\/cancers13174464","journal-title":"Cancers"},{"issue":"21","key":"346_CR21","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1001\/jama.297.21.2360","volume":"297","author":"P Kaurah","year":"2007","unstructured":"Kaurah P, MacMillan A, Boyd N et al (2007) Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. JAMA 297(21):2360\u20132372. https:\/\/doi.org\/10.1001\/jama.297.21.2360","journal-title":"JAMA"},{"key":"346_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1001\/jamasurg.2021.5118","volume":"157","author":"LA Gamble","year":"2022","unstructured":"Gamble LA, Rossi A, Fasaye GA et al (2022) Association between Hereditary lobular breast Cancer due to CDH1 variants and gastric Cancer risk. JAMA Surg 157:18\u201322. https:\/\/doi.org\/10.1001\/jamasurg.2021.5118","journal-title":"JAMA Surg"},{"key":"346_CR23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S1470-2045(22)00643-X","volume":"1","author":"J Garcia-Pelaez","year":"2023","unstructured":"Garcia-Pelaez J, Barbosa-Matos R, Lobo S et al (2023) Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the european Reference Network on genetic Tumour Risk Syndromes. Lancet Oncol 1:91\u2013106. https:\/\/doi.org\/10.1016\/S1470-2045(22)00643-X","journal-title":"Lancet Oncol"},{"key":"346_CR24","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/ncb3136","volume":"17","author":"T Lecuit","year":"2015","unstructured":"Lecuit T, Yap AS (2015) E-cadherin junctions as active mechanical integrators in tissue dynamics. Nat Cell Biol 17:533\u2013539. https:\/\/doi.org\/10.1038\/ncb3136","journal-title":"Nat Cell Biol"},{"key":"346_CR25","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1093\/hmg\/ddp046","volume":"18","author":"C Oliveira","year":"2009","unstructured":"Oliveira C, Senz J, Kaurah P et al (2009) Germline CDH1 deletions in hereditary diffuse gastric cancer families. Hum Mol Genet 18:1545\u20131555. https:\/\/doi.org\/10.1093\/hmg\/ddp046","journal-title":"Hum Mol Genet"},{"key":"346_CR26","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1002\/humu.23650","volume":"39","author":"K Lee","year":"2018","unstructured":"Lee K, Krempely K, Roberts ME, Anderson MJ et al (2018) Specifications of the ACMG\/AMP variant curation guidelines for the analysis of germline CDH1 sequence variants. Hum Mutat 39:1553\u20131568. https:\/\/doi.org\/10.1002\/humu.23650","journal-title":"Hum Mutat"},{"key":"346_CR27","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1136\/jmg-2022-108807","volume":"60","author":"X Luo","year":"2023","unstructured":"Luo X, Maciaszek JL, Thompson BA et al (2023) ClinGen CDH1 variant Curation Expert Panel. Optimising clinical care through CDH1-specific germline variant curation: improvement of clinical assertions and updated curation guidelines. J Med Genet 60:568\u2013575. https:\/\/doi.org\/10.1136\/jmg-2022-108807","journal-title":"J Med Genet"},{"key":"346_CR28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41525-022-00323-y","volume":"7","author":"C Horton","year":"2022","unstructured":"Horton C, Cass A, Conner BR et al (2022) Mutational and splicing landscape in a cohort of 43,000 patients tested for hereditary cancer. NPJ Genom Med 7:49. https:\/\/doi.org\/10.1038\/s41525-022-00323-y","journal-title":"NPJ Genom Med"},{"key":"346_CR29","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","volume":"176","author":"K Jaganathan","year":"2019","unstructured":"Jaganathan K, Kyriazopoulou Panagiotopoulou S, McRae JF et al (2019) Predicting Splicing from primary sequence with deep learning. Cell 176:535\u2013548e24. https:\/\/doi.org\/10.1016\/j.cell.2018.12.015","journal-title":"Cell"},{"key":"346_CR30","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, ACMG Laboratory Quality Assurance Committee (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet medicine: official J Am Coll Med Genet 17:405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet medicine: official J Am Coll Med Genet"},{"key":"346_CR31","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski KJ, Francioli LC, Tiao G et al (2020) The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581:434\u2013443. https:\/\/doi.org\/10.1038\/s41586-020-2308-7","journal-title":"Nature"},{"key":"346_CR32","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S1470-2045(23)00057-8","volume":"24","author":"B Asif","year":"2023","unstructured":"Asif B, Sarvestani AL, Gamble LA, Samaranayake SG, Famiglietti AL, Fasaye GA, Quezado M, Miettinen M, Korman L, Koh C, Heller T, Davis JL (2023) Cancer surveillance as an alternative to prophylactic total gastrectomy in hereditary diffuse gastric cancer: a prospective cohort study. Lancet Oncol 24:383\u2013391. https:\/\/doi.org\/10.1016\/S1470-2045(23)00057-8","journal-title":"Lancet Oncol"},{"key":"346_CR33","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S1470-2045(22)00700-8","volume":"24","author":"CYC Lee","year":"2023","unstructured":"Lee CYC, Olivier A, Honing J, Lydon AM, Richardson S, O\u2019Donovan M, Tischkowitz M, Fitzgerald RC, di Pietro M (2023) Endoscopic surveillance with systematic random biopsy for the early diagnosis of hereditary diffuse gastric cancer: a prospective 16-year longitudinal cohort study. Lancet Oncol 24:107\u2013116. https:\/\/doi.org\/10.1016\/S1470-2045(22)00700-8","journal-title":"Lancet Oncol"},{"key":"346_CR34","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1002\/humu.23555","volume":"39","author":"A Henrie","year":"2018","unstructured":"Henrie A, Hemphill SE, Ruiz-Schultz N et al (2018) ClinVar Miner: demonstrating utility of a web-based tool for viewing and filtering ClinVar data. Hum Mutat 39:1051\u20131060. https:\/\/doi.org\/10.1002\/humu.23555","journal-title":"Hum Mutat"},{"key":"346_CR35","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1001\/jama.2018.13152","volume":"320","author":"J Mersch","year":"2018","unstructured":"Mersch J, Brown N, Pirzadeh-Miller S et al (2018) Prevalence of variant reclassification following hereditary cancer genetic testing. JAMA - Journal of the American Medical Association 320:1266\u20131274. https:\/\/doi.org\/10.1001\/jama.2018.13152","journal-title":"JAMA - Journal of the American Medical Association"},{"key":"346_CR36","doi-asserted-by":"publisher","first-page":"417","DOI":"10.18632\/oncotarget.26501","volume":"10","author":"TP Slavin","year":"2019","unstructured":"Slavin TP, Manjarrez S, Pritchard CC et al (2019) The effects of genomic germline variant reclassification on clinical cancer care. Oncotarget 10:417\u2013423. https:\/\/doi.org\/10.18632\/oncotarget.26501","journal-title":"Oncotarget"},{"key":"346_CR37","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1093\/jamia\/ocac232","volume":"30","author":"J Casaletto","year":"2023","unstructured":"Casaletto J, Cline M, Shirts B (2023) Modeling the impact of data sharing on variant classification. J Am Med Inform Assoc 30:466\u2013474. https:\/\/doi.org\/10.1093\/jamia\/ocac232","journal-title":"J Am Med Inform Assoc"},{"key":"346_CR38","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/cge.12405","volume":"87","author":"ST Vadaparampil","year":"2015","unstructured":"Vadaparampil ST, Scherr CL, Cragun D et al (2015) Pre-test genetic counseling services for hereditary breast and ovarian cancer delivered by non-genetics professionals in the state of Florida. Clin Genet 87:473\u2013477. https:\/\/doi.org\/10.1111\/cge.12405","journal-title":"Clin Genet"},{"key":"346_CR39","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s10897-013-9605-3","volume":"23","author":"TA Bensend","year":"2014","unstructured":"Bensend TA, Veach PMC, Niendorf KB (2014) What\u2019s the harm? Genetic counselor perceptions of adverse effects of genetics service provision by non-genetics professionals. J Genet Couns 23:48\u201363. https:\/\/doi.org\/10.1007\/s10897-013-9605-3","journal-title":"J Genet Couns"},{"key":"346_CR40","first-page":"413","volume":"74","author":"KL Brierley","year":"2010","unstructured":"Brierley KL, Campfield D, Ducaine W et al (2010) Errors in delivery of cancer genetics services: implications for practice. Conn Med 74:413\u2013423","journal-title":"Conn Med"},{"key":"346_CR41","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1089\/gtmb.2012.0381","volume":"17","author":"T Pal","year":"2013","unstructured":"Pal T, Cragun D, Lewis C et al (2013) A statewide survey of practitioners to assess knowledge and clinical practices regarding hereditary breast and ovarian cancer. Genet Test Mol Biomarkers 17:367\u2013375. https:\/\/doi.org\/10.1089\/gtmb.2012.0381","journal-title":"Genet Test Mol Biomarkers"},{"key":"346_CR42","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1111\/cge.13917","volume":"99","author":"KE Donohue","year":"2021","unstructured":"Donohue KE, Gooch C, Katz A et al (2021) Pitfalls and challenges in genetic test interpretation: an exploration of genetic professionals experience with interpretation of results. Clin Genet 99:638\u2013649. https:\/\/doi.org\/10.1111\/cge.13917","journal-title":"Clin Genet"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-023-00346-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-023-00346-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-023-00346-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T14:02:08Z","timestamp":1695996128000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-023-00346-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,4]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["346"],"URL":"https:\/\/doi.org\/10.1007\/s10689-023-00346-z","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"type":"print","value":"1389-9600"},{"type":"electronic","value":"1573-7292"}],"subject":[],"published":{"date-parts":[[2023,8,4]]},"assertion":[{"value":"2 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"CH, CP, and TB are full time employees at Ambry Genetics. The remaining authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}